Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,810 | 928 | 99.4% |
| Education | $90.18 | 13 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,164 | 109 | $0 (2024) |
| Novo Nordisk Inc | $1,393 | 107 | $0 (2024) |
| ABBVIE INC. | $1,308 | 73 | $0 (2024) |
| PFIZER INC. | $1,290 | 118 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,130 | 82 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $665.47 | 55 | $0 (2024) |
| Lilly USA, LLC | $600.89 | 45 | $0 (2024) |
| GlaxoSmithKline, LLC. | $545.26 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $433.93 | 36 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $417.85 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,699 | 90 | ABBVIE INC. ($268.54) |
| 2023 | $1,979 | 113 | ABBVIE INC. ($368.69) |
| 2022 | $1,741 | 112 | ABBVIE INC. ($232.87) |
| 2021 | $2,090 | 136 | AbbVie Inc. ($332.73) |
| 2020 | $1,578 | 98 | AstraZeneca Pharmaceuticals LP ($316.17) |
| 2019 | $1,526 | 109 | PFIZER INC. ($315.39) |
| 2018 | $1,696 | 144 | AstraZeneca Pharmaceuticals LP ($339.84) |
| 2017 | $1,592 | 139 | AstraZeneca Pharmaceuticals LP ($230.22) |
All Payment Transactions
941 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/21/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.62 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Cardiovascular | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Obesity | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,805 | 2,550 | $396,560 | $104,140 |
| 2022 | 33 | 1,959 | 2,792 | $431,911 | $110,497 |
| 2021 | 29 | 2,038 | 2,813 | $307,092 | $143,131 |
| 2020 | 30 | 2,376 | 3,312 | $341,713 | $153,822 |
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 314 | 576 | $131,904 | $26,939 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 269 | 379 | $58,745 | $13,224 | 22.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 275 | 275 | $51,975 | $11,169 | 21.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 174 | $32,712 | $10,582 | 32.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 70 | $24,500 | $6,866 | 28.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 60 | 71 | $22,223 | $6,203 | 27.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 20 | $5,600 | $5,488 | 98.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 89 | 89 | $4,628 | $2,981 | 64.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 89 | 89 | $3,560 | $2,648 | 74.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 19 | $9,785 | $2,548 | 26.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 29 | 33 | $11,748 | $2,501 | 21.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 43 | 53 | $5,989 | $2,316 | 38.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 32 | 44 | $5,368 | $1,812 | 33.8% |
| 99235 | Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | Facility | 2023 | 11 | 11 | $5,280 | $1,355 | 25.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 83 | 129 | $2,580 | $1,228 | 47.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 16 | 16 | $2,128 | $1,114 | 52.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 81 | 110 | $4,400 | $1,067 | 24.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 100 | 114 | $2,280 | $925.42 | 40.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $3,757 | $860.28 | 22.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 23 | $920.00 | $684.25 | 74.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,485 | $554.65 | 37.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 32 | 128 | $2,560 | $526.58 | 20.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 24 | $1,248 | $247.90 | 19.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 30 | $420.00 | $151.45 | 36.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 41 | 45 | $765.00 | $150.37 | 19.7% |
About Dr. Steven Nelson, M.D
Dr. Steven Nelson, M.D is a Family Medicine healthcare provider based in Liberty, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164486908.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Nelson, M.D has received a total of $13,900 in payments from pharmaceutical and medical device companies, with $1,699 received in 2024. These payments were reported across 941 transactions from 76 companies. The most common payment nature is "Food and Beverage" ($13,810).
As a Medicare-enrolled provider, Nelson has provided services to 8,178 Medicare beneficiaries, totaling 11,467 services with total Medicare billing of $511,590. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Liberty, MO
- Active Since 04/17/2006
- Last Updated 01/30/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164486908
Products in Payments
- FARXIGA (Drug) $1,115
- JARDIANCE (Drug) $708.58
- Ozempic (Drug) $644.88
- SYMBICORT (Drug) $608.81
- VRAYLAR (Drug) $577.79
- XARELTO (Drug) $482.99
- VYVANSE (Drug) $467.37
- UBRELVY (Drug) $404.95
- TRULICITY (Drug) $378.63
- ELIQUIS (Drug) $358.94
- Rybelsus (Drug) $324.12
- CHANTIX (Drug) $313.45
- NURTEC ODT (Drug) $267.68
- STIOLTO RESPIMAT (Drug) $252.33
- LYRICA (Drug) $247.20
- QULIPTA (Drug) $232.77
- ENTRESTO (Drug) $219.30
- TRELEGY ELLIPTA (Drug) $216.73
- AIRSUPRA (Drug) $214.14
- ANORO (Drug) $173.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Liberty
Dr. Amy Parry, D.o, D.O
Family Medicine — Payments: $8,334
Jerome Waller, M.d, M.D
Family Medicine — Payments: $5,164
Dr. John Randolph, M.d, M.D
Family Medicine — Payments: $4,899
Dr. John Smart, D.o, D.O
Family Medicine — Payments: $4,007
Mark Walsh, Md, MD
Family Medicine — Payments: $2,453
Jay Patel, D.o, D.O
Family Medicine — Payments: $1,725